Episurf Medical to present at Redeye Growth Day today, June 1st, 2023

Episurf Medical (Nasdaq: EPIS B) will present at Redeye Growth Day today, June 1st, 2023. The event is arranged by Redeye and will be streamed live. The company will be represented by its CEO Pål Ryfors.

Time: 09:40 CEST
Format: 2 minutes live pitch followed by 18 minutes of Q&A

Link to the livestream Q&A (Stream 2):  https://www.redeye.se/events/871323/redeye-growth-day?tab=companypresentations  

Link to the accompanying pre-recorded presentation: https://www.redeye.se/video/company-prerecorded-presentation/912672/episurf-medical-3

The presentation will also be made available afterwards on our website www.episurf.com.

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: